Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Vicky Zhou
 + 450 word(s) 450 2020-12-15 07:44:32

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Zhou, V. ANTXR2 Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/4703 (accessed on 19 April 2024).
Zhou V. ANTXR2 Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/4703. Accessed April 19, 2024.
Zhou, Vicky. "ANTXR2 Gene" Encyclopedia, https://encyclopedia.pub/entry/4703 (accessed April 19, 2024).
Zhou, V. (2020, December 24). ANTXR2 Gene. In Encyclopedia. https://encyclopedia.pub/entry/4703
Zhou, Vicky. "ANTXR2 Gene." Encyclopedia. Web. 24 December, 2020.
ANTXR2 Gene
Edit
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/antxr2

ANTXR cell adhesion molecule 2

genes

1. Normal Function

The ANTXR2 gene provides instructions for making a protein that is found at the surface of many types of cells. The ANTXR2 protein is believed to interact with components of the extracellular matrix, which is the lattice of proteins and other molecules outside the cell. This matrix strengthens and supports connective tissues, such as skin, bone, cartilage, tendons, and ligaments.

The ANTXR2 protein is involved in the formation of tiny blood vessels (capillaries). It may also be important for maintaining the structure of basement membranes, which are thin, sheet-like extracellular matrix structures that separate and support cells in many connective tissues. Research suggests that the ANTXR2 protein aids in the breakdown of at least one type of extracellular matrix protein, ensuring the correct balance of proteins is maintained for normal functioning of muscles and connective tissues.

The ANTXR2 protein also acts as a receptor for the toxin that causes anthrax, allowing the toxin to attach to cells and trigger disease.

2. Health Conditions Related to Genetic Changes

Hyaline fibromatosis syndrome

More than 45 mutations in the ANTXR2 gene have been found to cause hyaline fibromatosis syndrome, a painful condition characterized by accumulation of a clear (hyaline) substance in different tissues in the body. The nature of the hyaline substance is unknown, but it likely contains extracellular matrix proteins, among other materials. Buildup of this material can cause firm lumps of noncancerous tissue (nodules) under the skin and in internal organs, joint deformities called contractures that restrict movement, and overgrowth of the gums. The severity of the signs and symptoms falls along a spectrum. The most severely affected individuals have severe diarrhea and recurrent infections and usually do not survive beyond early childhood. Individuals at the milder end of the spectrum typically survive into adulthood.

Some ANTXR2 gene mutations reduce or eliminate the amount of ANTXR2 protein at the surface of cells. Others are thought to impair the protein's ability to interact with extracellular matrix components. It is unclear what effect these mutations have in cells and tissues. Researchers suspect that gene mutations disrupt the formation of basement membranes, allowing a hyaline substance to leak through and build up in various body tissues. Alternatively, the mutations could impair the breakdown of excess extracellular matrix proteins, which then accumulate in tissues and lead to the signs and symptoms of hyaline fibromatosis syndrome.

It is unclear why the severity of hyaline fibromatosis syndrome varies among affected individuals. Some studies have indicated that the severity of the condition may be linked to where in the gene the mutation occurs.

3. Other Names for This Gene

  • anthrax toxin receptor 2
  • ANTR2_HUMAN
  • capillary morphogenesis protein 2
  • CMG-2
  • CMG2
  • FLJ31074
  • ISH
  • JHF
  • MGC111533
  • MGC45856

References

  1. Bürgi J, Kunz B, Abrami L, Deuquet J, Piersigilli A, Scholl-Bürgi S, Lausch E,Unger S, Superti-Furga A, Bonaldo P, van der Goot FG. CMG2/ANTXR2 regulatesextracellular collagen VI which accumulates in hyaline fibromatosis syndrome. NatCommun. 2017 Jun 12;8:15861. doi: 10.1038/ncomms15861.
  2. Deuquet J, Abrami L, Difeo A, Ramirez MC, Martignetti JA, van der Goot FG.Systemic hyalinosis mutations in the CMG2 ectodomain leading to loss of function through retention in the endoplasmic reticulum. Hum Mutat. 2009 Apr;30(4):583-9. doi: 10.1002/humu.20872.
  3. Deuquet J, Lausch E, Superti-Furga A, van der Goot FG. The dark sides ofcapillary morphogenesis gene 2. EMBO J. 2012 Jan 4;31(1):3-13. doi:10.1038/emboj.2011.442.
  4. Dowling O, Difeo A, Ramirez MC, Tukel T, Narla G, Bonafe L, Kayserili H,Yuksel-Apak M, Paller AS, Norton K, Teebi AS, Grum-Tokars V, Martin GS, Davis GE,Glucksman MJ, Martignetti JA. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemichyalinosis. Am J Hum Genet. 2003 Oct;73(4):957-66.
  5. El-Kamah GY, Fong K, El-Ruby M, Afifi HH, Clements SE, Lai-Cheong JE, Amr K,El-Darouti M, McGrath JA. Spectrum of mutations in the ANTXR2 (CMG2) gene ininfantile systemic hyalinosis and juvenile hyaline fibromatosis. Br J Dermatol.2010 Jul;163(1):213-5. doi: 10.1111/j.1365-2133.2010.09769.x.
  6. Liu S, Crown D, Miller-Randolph S, Moayeri M, Wang H, Hu H, Morley T, LepplaSH. Capillary morphogenesis protein-2 is the major receptor mediating lethalityof anthrax toxin in vivo. Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12424-9. doi: 10.1073/pnas.0905409106.
  7. Rahman N, Dunstan M, Teare MD, Hanks S, Edkins SJ, Hughes J, Bignell GR,Mancini G, Kleijer W, Campbell M, Keser G, Black C, Williams N, Arbour L, Warman M, Superti-Furga A, Futreal PA, Pope FM. The gene for juvenile hyalinefibromatosis maps to chromosome 4q21. Am J Hum Genet. 2002 Oct;71(4):975-80.
  8. Shieh JTC, Hoyme HE, Arbour LT. Hyaline Fibromatosis Syndrome. 2008 Feb 27[updated 2020 Jul 23]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): Universityof Washington, Seattle; 1993-2020. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK1525/
  9. Tanaka K, Ebihara T, Kusubata M, Adachi E, Arai M, Kawaguchi N, Utsunomiya J, Miki Y, Hiramoto M, Hattori S, Irie S. Abnormal collagen deposition in fibromasfrom patient with juvenile hyaline fibromatosis. J Dermatol Sci. 2009Sep;55(3):197-200. doi: 10.1016/j.jdermsci.2009.06.005.
  10. Yan SE, Lemmin T, Salvi S, Lausch E, Superti-Furga A, Rokicki D, Dal Peraro M,van der Goot FG. In-depth analysis of hyaline fibromatosis syndrome frameshiftmutations at the same site reveal the necessity of personalized therapy. HumMutat. 2013 Jul;34(7):1005-17. doi: 10.1002/humu.22324.
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Genetics & Heredity
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Vicky Zhou
View Times: 277
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback